Craig Adeyanju

InvestorPlace Contributor

Craig Adeyanju enjoys to unearth awesome growth and value stocks and educate investors about the companies behind them. He believes that the best companies to invest in are those that genuinely solve a problem.

His work has appeared on sites like TheStreet, The Motley Fool, Benzinga among others.

Recent Articles

Barrick Gold Is Streamlining to the Top of the Gold Pile

By Craig Adeyanju, InvestorPlace Contributor

It’s a good time for patient investors to get in ABX stock. An investment in Barrick Gold at the moment is a play on streamlined operation.

CVS Stock: CVS Health Finding Its Footing Without Tobacco

By Craig Adeyanju, InvestorPlace Contributor

CVS Health's stand against tobacco will work in its favor over the long-term, even if it causes CVS stock to stumble presently.

AMGN Stock: The Dark Underbelly of Amgen Earnings

By Craig Adeyanju, InvestorPlace Contributor

Amagen reported a stellar-looking earnings report, but a lot of its revenue increases were due to price hikes and not higher adoption.

GILD Stock: 2 Big Things You Should Know About Gilead Sciences

By Craig Adeyanju, InvestorPlace Contributor

Gilead is walloping its biotech peers on its way to cornering the HCV market. With improving sales, income and better cash management, GILD stock is a reliable long-term investment.

AAL Why Investors Should Be Happy With American Airlines

By Craig Adeyanju, InvestorPlace Contributor

AAL reported best quarterly net profit ever, slightly marred by revenue drop. AAL But investors should still be positive

Load More